ClinicalTrials.govpublic full text
A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia
beta-thalassemia, thalassemia, genetic diseases, inborn, hematologic diseases, hemoglobinopathies, crispr-cas9, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 892461
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.